223 related articles for article (PubMed ID: 27812135)
1. Characterization and Genetic Analyses of New Genes Coding for NOD2 Interacting Proteins.
Thiébaut R; Esmiol S; Lecine P; Mahfouz B; Hermant A; Nicoletti C; Parnis S; Perroy J; Borg JP; Pascoe L; Hugot JP; Ollendorff V
PLoS One; 2016; 11(11):e0165420. PubMed ID: 27812135
[TBL] [Abstract][Full Text] [Related]
2. The NOD2-RICK complex signals from the plasma membrane.
Lécine P; Esmiol S; Métais JY; Nicoletti C; Nourry C; McDonald C; Nunez G; Hugot JP; Borg JP; Ollendorff V
J Biol Chem; 2007 May; 282(20):15197-207. PubMed ID: 17355968
[TBL] [Abstract][Full Text] [Related]
3. A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretion.
Warner N; Burberry A; Pliakas M; McDonald C; Núñez G
J Biol Chem; 2014 Oct; 289(41):28213-24. PubMed ID: 25170077
[TBL] [Abstract][Full Text] [Related]
4. Crohn's Disease Variants of Nod2 Are Stabilized by the Critical Contact Region of Hsp70.
Schaefer AK; Wastyk HC; Mohanan V; Hou CW; Lauro ML; Melnyk JE; Burch JM; Grimes CL
Biochemistry; 2017 Aug; 56(34):4445-4448. PubMed ID: 28792733
[TBL] [Abstract][Full Text] [Related]
5. NOD2 gene mutations associate weakly with ulcerative colitis but not with Crohn's disease in Indian patients with inflammatory bowel disease.
Pugazhendhi S; Santhanam S; Venkataraman J; Creveaux I; Ramakrishna BS
Gene; 2013 Jan; 512(2):309-13. PubMed ID: 23085276
[TBL] [Abstract][Full Text] [Related]
6. The intermediate filament protein, vimentin, is a regulator of NOD2 activity.
Stevens C; Henderson P; Nimmo ER; Soares DC; Dogan B; Simpson KW; Barrett JC; ; Wilson DC; Satsangi J
Gut; 2013 May; 62(5):695-707. PubMed ID: 22684479
[TBL] [Abstract][Full Text] [Related]
7. TLE1 modifies the effects of NOD2 in the pathogenesis of Crohn's disease.
Nimmo ER; Stevens C; Phillips AM; Smith A; Drummond HE; Noble CL; Quail M; Davies G; Aldhous MC; Wilson DC; Satsangi J
Gastroenterology; 2011 Sep; 141(3):972-981.e1-2. PubMed ID: 21699783
[TBL] [Abstract][Full Text] [Related]
8. The NOD2 Single Nucleotide Polymorphism rs72796353 (IVS4+10 A>C) Is a Predictor for Perianal Fistulas in Patients with Crohn's Disease in the Absence of Other NOD2 Mutations.
Schnitzler F; Friedrich M; Wolf C; Stallhofer J; Angelberger M; Diegelmann J; Olszak T; Tillack C; Beigel F; Göke B; Glas J; Lohse P; Brand S
PLoS One; 2015; 10(7):e0116044. PubMed ID: 26147989
[TBL] [Abstract][Full Text] [Related]
9. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
10. Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases.
Yao Q
Semin Arthritis Rheum; 2013 Aug; 43(1):125-30. PubMed ID: 23352252
[TBL] [Abstract][Full Text] [Related]
11. PepT1 oligopeptide transporter (SLC15A1) gene polymorphism in inflammatory bowel disease.
Zucchelli M; Torkvist L; Bresso F; Halfvarson J; Hellquist A; Anedda F; Assadi G; Lindgren GB; Svanfeldt M; Janson M; Noble CL; Pettersson S; Lappalainen M; Paavola-Sakki P; Halme L; Färkkilä M; Turunen U; Satsangi J; Kontula K; Löfberg R; Kere J; D'Amato M
Inflamm Bowel Dis; 2009 Oct; 15(10):1562-9. PubMed ID: 19462432
[TBL] [Abstract][Full Text] [Related]
12. A Novel Rare Missense Variation of the
Frade-Proud'Hon-Clerc S; Smol T; Frenois F; Sand O; Vaillant E; Dhennin V; Bonnefond A; Froguel P; Fumery M; Guillon-Dellac N; Gower-Rousseau C; Vasseur F
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769939
[TBL] [Abstract][Full Text] [Related]
13. A novel motif in the Crohn's disease susceptibility protein, NOD2, allows TRAF4 to down-regulate innate immune responses.
Marinis JM; Homer CR; McDonald C; Abbott DW
J Biol Chem; 2011 Jan; 286(3):1938-50. PubMed ID: 21097508
[TBL] [Abstract][Full Text] [Related]
14. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
[TBL] [Abstract][Full Text] [Related]
15. Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease.
Li Q; Lee CH; Peters LA; Mastropaolo LA; Thoeni C; Elkadri A; Schwerd T; Zhu J; Zhang B; Zhao Y; Hao K; Dinarzo A; Hoffman G; Kidd BA; Murchie R; Al Adham Z; Guo C; Kotlarz D; Cutz E; Walters TD; Shouval DS; Curran M; Dobrin R; Brodmerkel C; Snapper SB; Klein C; Brumell JH; Hu M; Nanan R; Snanter-Nanan B; Wong M; Le Deist F; Haddad E; Roifman CM; Deslandres C; Griffiths AM; Gaskin KJ; Uhlig HH; Schadt EE; Muise AM
Gastroenterology; 2016 May; 150(5):1196-1207. PubMed ID: 26836588
[TBL] [Abstract][Full Text] [Related]
16. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan.
Bonen DK; Ogura Y; Nicolae DL; Inohara N; Saab L; Tanabe T; Chen FF; Foster SJ; Duerr RH; Brant SR; Cho JH; Nuñez G
Gastroenterology; 2003 Jan; 124(1):140-6. PubMed ID: 12512038
[TBL] [Abstract][Full Text] [Related]
17. The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study.
Kuenzig ME; Yim J; Coward S; Eksteen B; Seow CH; Barnabe C; Barkema HW; Silverberg MS; Lakatos PL; Beck PL; Fedorak R; Dieleman LA; Madsen K; Panaccione R; Ghosh S; Kaplan GG
EBioMedicine; 2017 Jul; 21():188-196. PubMed ID: 28668336
[TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
Strober W; Asano N; Fuss I; Kitani A; Watanabe T
Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
[TBL] [Abstract][Full Text] [Related]
19. Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease.
Negroni A; Stronati L; Pierdomenico M; Tirindelli D; Di Nardo G; Mancini V; Maiella G; Cucchiara S
Inflamm Bowel Dis; 2009 Aug; 15(8):1145-54. PubMed ID: 19266573
[TBL] [Abstract][Full Text] [Related]
20. Association of NOD2 with Crohn's disease in a homogenous Irish population.
Bairead E; Harmon DL; Curtis AM; Kelly Y; O'Leary C; Gardner M; Leahy DT; Vaughan P; Keegan D; O'Morain C; O'Donoghue D; Shanahan F; Parfrey NA; Quane KA
Eur J Hum Genet; 2003 Mar; 11(3):237-44. PubMed ID: 12673278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
